Invenio Wealth Partners’s AbbVie ABBV Stock Holding History

Invenio Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$549K	Sell	2,183 -33	-1%	-$7.1K	0.2%	53
2026 Q1	$482K	Buy	2,216 +376	+20%	+$83.4K	0.19%	55
2025 Q4	$420K	Sell	1,840 -33	-2%	-$7.52K	0.16%	64
2025 Q3	$434K	Sell	1,873 -155	-8%	-$31.6K	0.16%	64
2025 Q2	$376K	Sell	2,028 -146	-7%	-$27.1K	0.15%	69
2025 Q1	$455K	Sell	2,174 -1,393	-39%	-$271K	0.19%	52
2024 Q4	$634K	Sell	3,567 -6	-0.2%	-$1.1K	0.27%	48
2024 Q3	$706K	Sell	3,573 -39	-1%	-$7.28K	0.31%	42
2024 Q2	$620K	Sell	3,612 -486	-12%	-$80.5K	0.31%	45
2024 Q1	$746K	Sell	4,098 -702	-15%	-$121K	0.4%	39
2023 Q4	$744K	Buy	4,800 +37	+0.8%	+$5.39K	0.54%	37
2023 Q3	$710K	Sell	4,763 -266	-5%	-$39K	0.65%	35
2023 Q2	$678K	Buy	+5,029	New	+$737K	0.77%	28

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invenio Wealth Partners's ABBV Position: Q2 2026 in Review

Invenio Wealth Partners reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $7.1K and leaving 2,183 shares worth $549K. The position accounts for 0.2% of the portfolio, ranked #53.

Invenio Wealth Partners first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $746K in Q1 2024. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Invenio Wealth Partners held 2,183 shares of AbbVie worth $549K as of Q2 2026.
Invenio Wealth Partners sold 33 AbbVie shares in Q2 2026, an estimated $7.1K.
AbbVie made up 0.2% of Invenio Wealth Partners's portfolio in Q2 2026, its #53 holding.
Invenio Wealth Partners first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
Invenio Wealth Partners's AbbVie position peaked at $746K in Q1 2024.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Invenio Wealth Partners's 13F filing for Q2 2026, filed 30 Jul 2026.